AGEN

Agenus Inc.

14.63 USD
+0.07 (+0.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Agenus Inc. stock is up 18.46% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52% of the previous 24 June’s closed higher than May. In the last 6 Unusual Options Trades, there were 5 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
29 Apr 13:49 17 May, 2024 11.00 CALL 100 23
30 Apr 14:01 16 Aug, 2024 22.00 CALL 200 0
06 May 19:24 17 May, 2024 11.00 CALL 100 119
08 May 14:44 17 May, 2024 14.00 PUT 83 17
13 Jun 13:50 21 Jun, 2024 10.00 CALL 50 123
18 Jun 16:06 17 Jan, 2025 9.00 CALL 45 37

About Agenus Inc.

Agenus Inc. discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer.